Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Grander

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Nature Metabolism|January 10, 2025
TM6SF2 as new intestinal lipid playerHerbert Tilg, Christoph Grander
Polish Archives of Internal Medicine|July 4, 2018
Microbiota and diabetes: an increasingly relevant associationHerbert Tilg, Christoph Grander
Cardiovascular Research|June 26, 2023
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsChristoph Grander, Felix Grabherr, Herbert Tilg
Clinical Liver Disease|May 2, 2019
How does the microbiome affect liver disease?Herbert Tilg, Christoph Grander, Alexander R Moschen
Journal of Clinical and Translational Hepatology|January 1, 2024
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable LinkMaria Effenberger, Christoph Grander, Felix Grabherr, et al.
International Journal of Molecular Sciences|August 1, 2017
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple InteractionsTimon E Adolph, Christoph Grander, Felix Grabherr, et al.
Visceral Medicine|December 7, 2016
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic SyndromeChristoph Grander, Felix Grabherr, Alexander R Moschen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2019
ReplyBenedikt Schaefer, André Viveiros, Christoph Grander, et al.
Trends in Immunology|May 31, 2018
Liver-Microbiome Axis in Health and DiseaseTimon E Adolph, Christoph Grander, Alexander R Moschen, et al.
Therapeutic Advances in Endocrinology and Metabolism|November 28, 2022
MAFLD: what 2 years of the redefinition of fatty liver disease has taught usFelix Grabherr, Christoph Grander, Maria Effenberger, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Nature Metabolism|January 10, 2025
TM6SF2 as new intestinal lipid playerHerbert Tilg, Christoph Grander
Polish Archives of Internal Medicine|July 4, 2018
Microbiota and diabetes: an increasingly relevant associationHerbert Tilg, Christoph Grander
Cardiovascular Research|June 26, 2023
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsChristoph Grander, Felix Grabherr, Herbert Tilg
Clinical Liver Disease|May 2, 2019
How does the microbiome affect liver disease?Herbert Tilg, Christoph Grander, Alexander R Moschen
Journal of Clinical and Translational Hepatology|January 1, 2024
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable LinkMaria Effenberger, Christoph Grander, Felix Grabherr, et al.
International Journal of Molecular Sciences|August 1, 2017
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple InteractionsTimon E Adolph, Christoph Grander, Felix Grabherr, et al.
Visceral Medicine|December 7, 2016
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic SyndromeChristoph Grander, Felix Grabherr, Alexander R Moschen, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2019
ReplyBenedikt Schaefer, André Viveiros, Christoph Grander, et al.
Trends in Immunology|May 31, 2018
Liver-Microbiome Axis in Health and DiseaseTimon E Adolph, Christoph Grander, Alexander R Moschen, et al.
Therapeutic Advances in Endocrinology and Metabolism|November 28, 2022
MAFLD: what 2 years of the redefinition of fatty liver disease has taught usFelix Grabherr, Christoph Grander, Maria Effenberger, et al.
Pageof 4